Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Invested Capital (2022 - 2025)

Autolus Therapeutics' Return on Invested Capital history spans 4 years, with the latest figure at 1.23% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 69.0% year-over-year to 1.23%; the TTM value through Dec 2025 reached 1.23%, down 69.0%, while the annual FY2025 figure was 0.9%, 0.0% changed from the prior year.
  • Return on Invested Capital reached 1.23% in Q4 2025 per AUTL's latest filing, down from 0.91% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.35% in Q2 2024 to a low of 1.23% in Q4 2023.
  • Average Return on Invested Capital over 4 years is 0.68%, with a median of 0.62% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: surged 69bps in 2024, then crashed -69bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 0.62% in 2022, then plummeted by -98bps to 1.23% in 2023, then skyrocketed by 56bps to 0.54% in 2024, then crashed by -128bps to 1.23% in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Return on Invested Capital are 1.23% (Q4 2025), 0.91% (Q3 2025), and 0.77% (Q2 2025).